Democratising proteomics for cancer and beyond
Drug Discovery World
APRIL 14, 2023
At the beginning of 2023, proteomics company Nautilus Biotechnology announced a partnership with the Translational Genomics Research Institute (TGen), to study the specific proteins at work in the rare and often fatal childhood cancer, diffuse intrinsic pontine glioma (DIPG). BMC Bioinformatics. 2013;14 Suppl 2(Suppl 2):S24.
Let's personalize your content